Jan 18, 2023
1:200
For every 200 shares held, investors received 1. The price per share adjusted from $0.03 to $0.00.
The split itself did not change the total investment value.
Arch Therapeutics, Inc. (ARTH) trades on the Other OTC in the Biotechnology industry.
Arch Therapeutics, Inc. company overviewThe latest split shown was on January 18, 2023. It was a 1-for-200 reverse split, so shareholders received 1 share for every 200 they held.
This history records 2 splits between May 28, 2013 and January 18, 2023.